Tobin James R
SEC-identified person · CIK 1190128 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Transmedics Group, Inc. TMDX | Director | filed 2019–2026 |
| Globus Medical INC GMED | Director | filed 2015–2026 |
| Lyra Therapeutics, Inc. LYRA | Director | filed 2022–2025 |
| Oxford Immunotec Global PLC OXFD | Director | filed 2014–2021 |
| Corindus Vascular Robotics, Inc. CVRS | Director | filed 2018–2019 |
| Chiasma, INC CHMA | Director | filed 2015–2016 |
| Curis INC CRIS | Director | filed 2006–2015 |
| Boston Scientific Corp bsx | Director · President & CEO | filed 2008–2009 |
| Applied Biosystems INC. ABI/CRA | Director | filed 2006–2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.